NCT04140630

Brief Summary

Objective: To investigate in real-life conditions passive exposure to aerosols from the use of e-cigarettes among people who cohabit with e-cigarette users. A secondary objective is to investigate passive exposure to emissions from the use of conventional cigarettes and heated tobacco products among people who cohabit with users of these tobacco products. Study design: This is an observational study conducted in four types of households: a) Homes with one exclusive e-cigarette user and at least one non-user (non-smoker), and no other users of any type of tobacco products. In these homes, one non-user and one user will be included in the study as participants ("type A" homes); b) Homes with one exclusive heated tobacco product (HTP) user and at least one non-user (non-smoker), and no other users of any type of tobacco products or e-cigarettes. In these homes, one non-user and one user will be included in the study as participants ("type B" homes); c) Homes with one exclusive manufactured cigarette smoker (not roll-your-own) and at least one non-smoker, and no other users of any type of tobacco products or e-cigarettes. In these homes, one non-smoker and one smoker will be included in the study as participants ("type C" homes); and d) Homes where no one uses e-cigarettes or consumes any other type of tobacco products (smoke-free homes). In these homes, one adult volunteer will be included in the study as a participant ("type D" homes). The study will be conducted in 4 countries: Greece (Athens), Italy (Milan), Spain (Barcelona) and the UK (Edinburgh). Overall, the sample in each participating country will consist of the types of participants mentioned above, with a total of 250 participants. Measurements: Passive exposure to e-cigarette aerosols will be assessed by measuring particulate matter (PM2.5) and airborne nicotine in the main room of homes during 7 days. Participants' saliva samples will be collected for nicotine and cotinine assessment. In addition, participants will be asked to fill in a personal diary about the use of e-cigarettes, second-hand exposure to e-cigarette aerosols (SHA) and exposure to second-hand smoke (SHS) produced by the use of conventional cigarettes.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Mar 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 1, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

October 1, 2019

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2019

Completed
27 days until next milestone

First Posted

Study publicly available on registry

October 28, 2019

Completed
Last Updated

October 28, 2019

Status Verified

October 1, 2019

Enrollment Period

7 months

First QC Date

October 1, 2019

Last Update Submit

October 24, 2019

Conditions

Keywords

vapingelectronic cigarettepassive exposure

Outcome Measures

Primary Outcomes (1)

  • Airborne nicotine concentration (mg/m3)

    Median airborne nicotine concentration (1h measurements with active sampling and 7-day continuous of passive sampling) in the home environment

    7 days

Secondary Outcomes (3)

  • Particulate matter concentration (PM2.5; in mg/m3)

    7 days

  • Nicotine, cotinine, TSNAs and propylene glycole concentrations in saliva samples (in ng/ml)

    1st day and the 7th day (pre-; post)

  • Metals, nicotine, cotinine and TSNAs concentrations in urine samples (in ng/ml)

    One measurement; day 7 of the observational study

Study Arms (4)

E-cigarette users and bystanders

Households with one e-cigarette user (adult (18 years old and above); e-cigarette exclusive user for at least 1 month; daily use of e-cigarettes inside home; cohabiting with at least one non-tobacco product nor e-cigarette user; other household members should not be users of any tobacco products or e-cigarettes) and one bystander cohabiting with the user

Other: No intervention

Conventional cigarette smokers and bystanders

Households with one smoker (adult (18 years old and above; manufactured cigarette exclusive smoker for at least 6 months; daily smoking inside home; cohabiting with at least one non-tobacco product nor e-cigarette user; other household members should not be users of tobacco products or e-cigarettes) and one bystander cohabiting with the smoker

Other: No intervention

Heated tobacco product users and bystanders

Households with one user of the heated tobacco product, HTP (adult (18 years old and above; • HTP exclusive user for at least 1 month; daily use of HTP inside home; cohabiting with at least one non-tobacco product nor e-cigarette user; other household members should not be users of tobacco products or e-cigarettes) and one bystander cohabiting with the user

Other: No intervention

Non-smokers and non-users (control)

Smoke free households (participants should be adult (18 years old and above), non e-cigarette user (never or former e-cigarette user \>1 month), non-user of any kind of tobacco product (never or former user \>1 month), and other household members should not be users of tobacco products or e-cigarettes

Other: No intervention

Interventions

No intervention; 1 week observational study

Conventional cigarette smokers and bystandersE-cigarette users and bystandersHeated tobacco product users and bystandersNon-smokers and non-users (control)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Overall, the sample in each participating country will consist of these types of participants: Type A 20 e-cigarette users 20 non-users cohabiting with e-cigarette users Type B\* 5 heated tobacco product users 5 non-users cohabiting with heated tobacco product users Type C 5 conventional cigarette smokers 5 non-smokers cohabiting with conventional cigarette smokers Type D 5 non-smokers/non-users living in smoke/e-cigarette free homes

You may qualify if:

  • Non-e-cigarette and non-tobacco-product users
  • Adult (18 years old and above)
  • Non e-cigarette user (never or former e-cigarette user \>1 month)
  • Non-user of any kind of tobacco product (never or former user \>1 month)
  • \[Only for type D homes\]: other household members should not be users of tobacco products or e-cigarettes
  • E-cigarette users
  • Adult (18 years old and above)
  • E-cigarette exclusive user for at least 1 month
  • Daily use of e-cigarettes inside home
  • Cohabiting with at least one non-tobacco product nor e-cigarette user
  • Other household members should not be users of any tobacco products or e-cigarettes
  • Heated tobacco product users
  • Adult (18 years old and above)
  • HTP exclusive user for at least 1 month
  • Daily use of HTP inside home
  • +8 more criteria

You may not qualify if:

  • For all participants:
  • To be daily exposed to SHS from tobacco products or to SHA from e-cigarettes in places other than home.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Catalan Institute of Oncology

Barcelona, 08908, Spain

RECRUITING

Related Links

MeSH Terms

Conditions

Vaping

Condition Hierarchy (Ancestors)

SmokingBehavior

Study Officials

  • Esteve Fernández, Dr

    Catalan Institute of Oncology (ICO) // Bellvitge Biomedical Research Institute (IDIBELL)

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Esteve Fernández, Dr

CONTACT

Marcela Fu, Dr

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 1, 2019

First Posted

October 28, 2019

Study Start

March 1, 2019

Primary Completion

October 1, 2019

Study Completion

October 1, 2019

Last Updated

October 28, 2019

Record last verified: 2019-10

Data Sharing

IPD Sharing
Will not share

Locations